YUHSpace: Browsing DSpace
menu
About
Yonsei University Medical Library
검색
All
Title
Author
Keyword / MeSH
Year
Journal Title
Contains
Equals
YUHASpace Repository
YUHSpace
About YUHSpace
Guildeline
BROWSE
Colleges & Departments
Yonsei Authors
Titles
Journal Titles
Publication Year
YUHS Publication
(연세의료원 간행물)
YUHSpace
1. College of Medicine (의과대학)
BioMedical Science Institute (의생명과학부)
1. Journal Papers
Browsing "1. Journal Papers" by Author : 4740
All
A
B
C
D
E
F
G
H
I
J
K
L
M
N
O
P
Q
R
S
T
U
V
W
X
Y
Z
가
나
다
라
마
바
사
아
자
차
카
타
파
하
All
가
나
다
라
마
바
사
아
자
차
카
타
파
하
A
B
C
D
E
F
G
H
I
J
K
L
M
N
O
P
Q
R
S
T
U
V
W
X
Y
Z
or enter first few letters:
Sort by:
title
issue date
submit date
In order:
Ascending
Descending
Results/Page
5
10
15
20
25
30
35
40
45
50
55
60
65
70
75
80
85
90
95
100
Authors/Record:
All
1
5
10
15
20
25
30
35
40
45
50
Showing results 7 to 25 of 25
This table browses all dspace content
Issue Date
Title
Journal Title
2021
Distinct Characteristics and Clinical Outcomes to Predict the Emergence of MET Amplification in Patients with Non-Small Cell Lung Cancer Who Developed Resistance after Treatment with Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitors
CANCERS
2021
Dynamic changes in circulating PD-1(+)CD8(+)T lymphocytes for predicting treatment response to PD-1 blockade in patients with non-small-cell lung cancer
EUROPEAN JOURNAL OF CANCER
2018
Enhancer Remodeling and MicroRNA Alterations Are Associated with Acquired Resistance to ALK Inhibitors.
CANCER RESEARCH
2018
ERK-dependent IL-6 autocrine signaling mediates adaptive resistance to pan-PI3K inhibitor BKM120 in head and neck squamous cell carcinoma
ONCOGENE
2020
Establishment and characterization of patient-derived xenografts as paraclinical models for head and neck cancer
BMC CANCER
2018
Establishment of a platform of non-small-cell lung cancer patient-derived xenografts with clinical and genomic annotation
LUNG CANCER
2019
Hyperprogressive disease during PD-1/PD-L1 blockade in patients with non-small-cell lung cancer
Annals of Oncology
2022
Molecular landscape of osimertinib resistance in patients and patient-derived preclinical models
THERAPEUTIC ADVANCES IN MEDICAL ONCOLOGY
2020
Mouse-human co-clinical trials demonstrate superior anti-tumour effects of buparlisib (BKM120) and cetuximab combination in squamous cell carcinoma of head and neck
BRITISH JOURNAL OF CANCER
2019
Patient-Derived Cells to Guide Targeted Therapy for Advanced Lung Adenocarcinoma
SCIENTIFIC REPORTS
2016
PD-L1 expression on immune cells, but not on tumor cells, is a favorable prognostic factor for head and neck cancer patients
SCIENTIFIC REPORTS
2020
Peripheral natural killer cells and myeloid-derived suppressor cells correlate with anti-PD-1 responses in non-small cell lung cancer
SCIENTIFIC REPORTS
2023
Personalized Biomarker-Based Umbrella Trial for Patients With Recurrent or Metastatic Head and Neck Squamous Cell Carcinoma: KCSG HN 15-16 TRIUMPH Trial
JOURNAL OF CLINICAL ONCOLOGY
2023
Polo-like Kinase 4: A Multifaceted Marker Linking Tumor Aggressiveness and Unfavorable Prognosis, and Insights into Therapeutic Strategies
CANCERS
2022
Primary Tumor Suppression and Systemic Immune Activation of Macrophages through the Sting Pathway in Metastatic Skin Tumor
YONSEI MEDICAL JOURNAL
2020
Repotrectinib Exhibits Potent Antitumor Activity in Treatment-Naïve and Solvent-Front-Mutant ROS1-Rearranged Non-Small Cell Lung Cancer
CLINICAL CANCER RESEARCH
2019
Targeting YAP to overcome acquired resistance to ALK inhibitors in ALK-rearranged lung cancer
EMBO MOLECULAR MEDICINE
2019
YH25448, an Irreversible EGFR-TKI with Potent Intracranial Activity in EGFR Mutant Non-Small Cell Lung Cancer
CLINICAL CANCER RESEARCH
2022
YH29407 with anti-PD-1 ameliorates anti-tumor effects via increased T cell functionality and antigen presenting machinery in the tumor microenvironment
FRONTIERS IN CHEMISTRY
1
Browse
Communities & Collections
Titles
Yonsei Authors
Journal Titles
By date
Links
About
Yonsei University Medical Library